PRS313

1. PRS313 predicts breast cancer in humans (AUC 0.59 (95% CI: 0.56–0.62)).

   “The European-derived PRS313 achieved the highest discriminatory performance in African populations (pooled AUC = 0.59, 95% CI: 0.56–0.62”

   Humansin African populationsfemales

   Performance of Polygenic Risk Scores for Breast Cancer in African Populations: A Systematic Review and Meta-Analysis

   Research Square·17 Sep 2026Preprint

More on Breast cancer